SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-011175
Filing Date
2018-10-15
Accepted
2018-10-15 17:24:54
Documents
3
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT qbiomed10-q.htm 10-Q 563480
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit311.htm EX-31.1 19382
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit321.htm EX-32.1 8461
  Complete submission text file 0001654954-18-011175.txt   592428
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 181123104
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1